News

Featured News

  • 2019 |
  • 2018 |
  • 2017 |
  • Press Release | January 4, 2019

    Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

    Read More

    News | January 3, 2019

    Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809

    Read More

    News | December 18, 2018

    Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita

    Read More

    Press Release | December 18, 2018

    Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform

    Read More